- Duration
- One to two years, depending on the applicant's diagnostic angiography skills.
- Deadline
- The page lists ERAS applications opening 12 November 2026 and programme review beginning 2 December 2026. Its season-end line has inconsistent year labels; obtain the definitive deadline from ERAS/the programme.
- Funding
- The official page does not publish funding details.
- Exposure
- Acute stroke interventions, carotid disease, cerebral aneurysms, AVMs/fistulas and neurovascular oncology (tumour and extracranial embolization), with paediatric neurovascular disease as an opportunity; about 80% clinical and 20% research at Tampa General Hospital.
Source & missing information (14)
Application status: Advertises the 2028–2030 cohort, but the listed ERAS opening date (12 November 2026) is still in the future as of 18 October 2026. The page's season-end labels are inconsistent.
Funding: The official page does not publish funding details.
Exposure: Acute stroke interventions, carotid disease, cerebral aneurysms, AVMs/fistulas and neurovascular oncology (tumour and extracranial embolization), with paediatric neurovascular disease as an opportunity; about 80% clinical and 20% research at Tampa General Hospital.
Eligibility: The programme-specific application page requires ACGME-accredited preliminary residency training; an international medical degree alone does not establish eligibility.
Still to confirm: Current status · Positions · Participation level · Training level · International eligibility · Medical registration · Examinations · Language · Visa / work authorisation · Benefits · Fees · Insurance · Accommodation · Application documents
Source: Official USF Health neuroendovascular fellowship page. Reviewed 15 Oct 2026. Status reflects the last review, not a live vacancy check. Completeness is not a quality rating.
